IP Library Granted Patent US 8,026,101
Granted Patent B2
US 8,026,101 · App. 11/091,283 · Granted Sep 27, 2011

Failure detection in automated clinical analyzers

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,026,101
App. No.
11/091,283
Granted
Sep 27, 2011
Kind
B2
Abstract

The invention is a method for detecting failures in an analyzer for conducting clinical assays. Potential errors that can result in assay failures in an analyzer are identified, as are their potential sources. The probability that an error source so identified will result in a clinically significant error is also determined. Available potential detection measures corresponding to the source of potential errors are identified with a combination of such measures selected and implemented based on their probability of detecting such errors within an acceptable limit with a concomitant low probability of the false detection of an assay failure. Each of the measures selected are functionally independent of others chosen to address the source of the error and are not subject to the same inherent means of failed detection. Applications of the method in a clinical analyzer are also presented.

Claims (29)

1. A method of detecting fluid metering failures comprising:

a) rapidly flushing a fluid delivery vessel with a fluid so that a foam is formed by the fluid,

b) measuring the height of the foam within a vessel without measuring a height of a liquid underlying the foam,

c) evaluating the sufficiency of the volume of the fluid based on the height of the foam, and

d) identifying insufficient volumes as fluid metering failures.

2. The method of claim 1 wherein said measuring step is conducted by a level sensor.

3. The method of claim 2 wherein said level sensor is a pressure sensing, capacitance, reflected energy, or visual detection sensor.

4. The method of claim 1 wherein the method of detecting fluid metering failures is fast enough so that it can be done without impacting system throughput.

5. The method of claim 1 wherein the method is able to detect:

a) partially plugged reagent probes,

b) fully plugged reagent probes, and

c) failed valves.

6. The method of claim 1 wherein said measuring step is conducted by a capacitance sensor.

7. The method of claim 1 further comprising the step of determining the volume of the fluid.

8. A method of detecting analyzer failures comprising:

I) a) rapidly flushing a fluid delivery vessel with a fluid so that a foam is formed by the fluid,

b) measuring the height of the foam within a the vessel without measuring a height of

a liquid underlying the foam,

c) determining the volume of the fluid,

d) evaluating the sufficiency of the volume of the fluid,

e) identifying insufficient volumes as fluid metering failures, and

II) a) aspirating sample in a fluid delivery device,

b) metering sample into a dilution vessel,

c) metering diluent into said dilution vessel,

d) determining the volume of b) and c),

e) determining the sufficiency of the measurement taken in d), and

f) identifying as a failure insufficiencies identified in e).

9. The method of claim 8 further comprising:

III) employing a carryover free fluid delivery and verification device comprising a hollow vessel through which fluid is dispensed having an end out of which fluid is dispensed, said vessel being in contact with a transducer, wherein said end out of which fluid is dispensed comprises a geometry resistant to carryover.

Assignments (5)
RELEASE (REEL 060220 / FRAME 0711) Recorded Aug 22, 2025
From: BANK OF AMERICA, N.A.
To: QUIDEL CORPORATION; BIOHELIX CORPORATION; DIAGNOSTIC HYBRIDS, INC.; QUIDEL CARDIOVASCULAR INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.
Reel/Frame 072577/0536 →
RELEASE OF SECURITY INTEREST Recorded May 31, 2022
From: BANK OF AMERICA, N.A.
To: ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC
Reel/Frame 060219/0571 →
SECURITY AGREEMENT Recorded May 31, 2022
From: QUIDEL CORPORATION; BIOHELIX CORPORATION; DIAGNOSTIC HYBRIDS, INC.; QUIDEL CARDIOVASCULAR INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 060220/0711 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 19, 2018
From: BOWER, RANDY KRISTOPHER; MACDONALD, STUART GILMOUR; SHAW, JAMES DAVID; SIMON, MARK ALAN; AVDENKO, MICHAEL; DAMBRA, JOSEPH JOHN; HYDE, DAVID DONALD; JACOBS, MERRIT NYLES; RIALL, JAMES DANIEL
To: ORTHO-CLINICAL DIAGNOSTICS, INC.
Reel/Frame 047546/0833 →
SECURITY INTEREST Recorded Jul 3, 2014
From: ORTHO-CLINICAL DIAGNOSTICS, INC; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 033276/0104 →